WO1997034553A1 - Bandage - Google Patents
Bandage Download PDFInfo
- Publication number
- WO1997034553A1 WO1997034553A1 PCT/GB1997/000784 GB9700784W WO9734553A1 WO 1997034553 A1 WO1997034553 A1 WO 1997034553A1 GB 9700784 W GB9700784 W GB 9700784W WO 9734553 A1 WO9734553 A1 WO 9734553A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- bandage
- skin
- layers
- filaments
- bandages
- Prior art date
Links
- 239000002861 polymer material Substances 0.000 claims abstract 2
- 230000001225 therapeutic effect Effects 0.000 claims abstract 2
- 239000000463 material Substances 0.000 claims description 20
- 230000002745 absorbent Effects 0.000 claims description 2
- 239000002250 absorbent Substances 0.000 claims description 2
- 239000000945 filler Substances 0.000 claims description 2
- 239000010410 layer Substances 0.000 description 13
- 210000003491 skin Anatomy 0.000 description 13
- 230000001070 adhesive effect Effects 0.000 description 10
- 239000000853 adhesive Substances 0.000 description 9
- 208000027418 Wounds and injury Diseases 0.000 description 7
- 206010052428 Wound Diseases 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 239000004744 fabric Substances 0.000 description 5
- 230000006835 compression Effects 0.000 description 4
- 238000007906 compression Methods 0.000 description 4
- 239000011148 porous material Substances 0.000 description 4
- 210000002615 epidermis Anatomy 0.000 description 3
- 230000035876 healing Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 230000029663 wound healing Effects 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 2
- 230000001464 adherent effect Effects 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 229920001971 elastomer Polymers 0.000 description 2
- 239000000806 elastomer Substances 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 210000003780 hair follicle Anatomy 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 210000000106 sweat gland Anatomy 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 1
- 208000010040 Sprains and Strains Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 239000003522 acrylic cement Substances 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 230000000721 bacterilogical effect Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000013013 elastic material Substances 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 238000013021 overheating Methods 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- XOIQMTLWECTKJL-HXPDMXKUSA-M sodium;(3r,4s)-4-[(2s,5r,7s,8r,9s)-2-[(2r,5s)-5-ethyl-5-[(2r,3s,5r)-5-[(2s,3s,5r,6r)-6-hydroxy-6-(hydroxymethyl)-3,5-dimethyloxan-2-yl]-3-methyloxolan-2-yl]oxolan-2-yl]-7-hydroxy-2,8-dimethyl-1,10-dioxaspiro[4.5]decan-9-yl]-3-methoxy-2-methylpentanoate Chemical group [Na+].C([C@@](O1)(C)[C@H]2CC[C@@](O2)(CC)[C@H]2[C@H](C[C@@H](O2)[C@@H]2[C@H](C[C@@H](C)[C@](O)(CO)O2)C)C)C[C@@]21C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)[C@@H](OC)C(C)C([O-])=O)O2 XOIQMTLWECTKJL-HXPDMXKUSA-M 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/02—Adhesive bandages or dressings
- A61F13/0273—Adhesive bandages for winding around limb, trunk or head, e.g. cohesive
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00089—Wound bandages
- A61F2013/00119—Wound bandages elastic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00365—Plasters use
- A61F2013/00489—Plasters use for bracing or strapping
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00544—Plasters form or structure
- A61F2013/00548—Plasters form or structure net
Definitions
- the invention relates to a new application of a non-woven integral elasticised sheet net material as a bandage.
- Surgical dressings and plasters have been developed for the following purposes: 1. The protection of the healing wound. 2. The prevention of contamination of the environment with wound exudate which may contain bacteria.
- Skin is normally infested with bacteria which present no problem to the host, provided that normal environment of the skin is maintained and the openings of the hair follicles and the ducts of the sweat glands are not occluded.
- the epidermis is permeable to water vapour and gases. In injuries where the epidermis is removed, the loss per unit area may increase tenfold.
- the surface temperature of the skin is less than body temperature. Occlusion of the surface of the skin not only prevents the evaporation of water vapour and a rise of surface temperature, but causes a quantitative increase in the bacterial flora.
- Bacteriological studies have shown that under a microporous water vapour-permeable dressing, the quantitative bacterial count is less than under occlusive dressings, and the incidence of recovery of pathogenic organisms is greatly reduced.
- woven bandages can be stretched along their length but do not stretch sideways. These products are most commonly used to retain dressings in position or in the treatment of sprains to restrict movement, to limit oedema in dependent parts and to hold large dressings in position. They are commonly known as supporting bandages.
- the use of adhesive may cause considerable stresses and strains to develop at the adhesive/epidermal interface within the epidermis and at the epidermal/dermal junction, which may result in disruption of the tissues. Sweat glands and hair follicles may become occluded by the adhesive, and the evaporation of water vapour may be prevented.
- Microporous tape made from a non-woven fibre with ' acrylic adhesives. Acrylic adhesive can be used repeatedly without causing trauma to the outer skin layers. There is permeability to liquid or water vapour only if applied as a single layer. However with overlapping, these advantages are lost.
- An example is Micropore tape marketed by 3M. This type of tape does not stretch and cannot be used for compression.
- a bandage is made of an elastomeric net-like sheet material which by virtue of an increased friction coefficient does not slip when overlapped, with multi-layering. It may have means whereby it can interlock with itself, as it is overlapped on itself when wound around a part. This is achieved by increasing the thickness and altering the shape at the cross-over points. When layered on itself, the cross-over points will lock into the pores of the net/mesh.
- the self-locking bandage is of a different design to (d) .
- the novel bandage is an integral elastopolymer mesh/net and, where the filaments intersect with each other (the junctures) , the intersections are thickened in various shapes by increasing the volume of the polymer, preferably but not necessarily at each junction or intersection in three dimensions, so that there is a marked nubbing of the intersections as a "knob” or "blob” or "hook” .
- the elasticised bandage of the invention is stretched and applied (e.g. to a limb) , in multilayering or overlapping on itself the projections at the junctions of any one layer of the bandage interlock with both the adjacent inner and outer layers.
- the interlocking action combined with the high co-efficient of friction of the elastic polymer net material prevents the bandage from slipping and it thus maintains its conformity and pressure as required.
- the juncture points or "high spots" may be 5-10 times the thickness of the filaments and may be round, elliptical or squarish or any shape according to its method of manufacture, whether extrusion or moulding.
- the pores of the netting may be square, rectangular, round or any shape depending on the technique of manufacture.
- the elastomer net may stretch in any direction with stretching ratios of from 3/1 to 10/1.
- the holes in the net are of such a size that the skin is never completely occluded. Because it is a net-like material with large holes it allows perspiration and with cooling of the skin prevents overheating at the surface.
- the mesh dimension is substantially larger than the filaments, so that the fabric has a high open area.
- the mesh size may be 0.5 to 10, e.g. 1.5 to 5, mm, while the filament size may be 0.1 to 2.5 mm, for example 0.2 to 1.5 mm.
- This high ratio e.g. of 1:1 to 25:1, means that, when layers of a strip of material according to the invention are superimposed after the strip is wrapped around a body part, the body is not occluded. This may assist healing, and permits washing.
- protuberances allow superimposed layers to interlock.
- the protuberances may be provided on one or both faces of the material. If provided on one face only, the other face will usually be the body-contacting face.
- the protuberances will most conveniently be provided at the intersections of the filaments of the material, as has previously been proposed in order to provide increased strength at the intersections, although they may also be present elsewhere on the filaments. These protuberances do not need to be accurately proportioned to fit into the pores of the fabric.
- the accompanying drawing shows a highly schematic partial plan view of material for use in the invention and also a schematic sectional view of the material when wrapped around on itself, e.g. over a wound (not shown) .
- This view may be considered as an expanded section, or in a state prior to tightening, when the layers are brought into closer contact.
- the protuberances are staggered in superimposed layers, so that they interlock with the open mesh in one or both adjacent layers.
- Another application of the elastomer netting as described comprises introducing a "filler" in the openings, e.g. an absorbent, air-permeable material. Such a material need not limit the elasticity or compromise the interlocking of the intersecting "knobs".
- the openings of the net material may be filled with a cotton or synthetic wool type material, or paper material in a thin layer in such a way as to allow the expansile or stretching nature of the intersecting filaments.
- the elastic net bandage is able to incorporate a material for absorbency but remains compliant enough to allow the projecting junctions to enter the holes.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Materials For Medical Uses (AREA)
Abstract
An elongate strip of an integral reticulated elastomeric polymer material, in which the mesh dimension thereof is substantially larger than the filaments, and which has surface protuberances, is appropriate for therapeutic use as a bandage by wrapping it around a body part so that layers thereof are superimposed and interlock without occlusion of the body.
Description
BANDAGE Field of the Invention
The invention relates to a new application of a non-woven integral elasticised sheet net material as a bandage.
Background of the Invention
Surgical dressings and plasters have been developed for the following purposes: 1. The protection of the healing wound. 2. The prevention of contamination of the environment with wound exudate which may contain bacteria.
3. The retention of a dressing or a medicament in contact with the surface of the body.
4. The restriction of movement of part of the body by traction or compression.
5. By maintaining compression, the prevention of accumulation of tissue fluid in a dependent part. There is no ideal product. Choice will be a compromise and will depend on an appreciation of the salient features of the anatomy and physiology or normal skin and the conditions to which it will be exposed.
Skin is normally infested with bacteria which present no problem to the host, provided that normal environment of the skin is maintained and the openings of the hair follicles and the ducts of the sweat glands are not occluded. Besides being permeable to the water lost by active sweating, the epidermis is permeable to water vapour and gases. In injuries where the epidermis is removed, the loss per unit area may increase tenfold. Under normal conditions, the surface temperature of the skin is less than body temperature. Occlusion of the surface of the skin not only prevents the evaporation of water vapour and a rise of surface temperature, but causes a quantitative increase in the bacterial flora. Bacteriological studies have shown that under a microporous water vapour-permeable dressing, the quantitative bacterial count is less than
under occlusive dressings, and the incidence of recovery of pathogenic organisms is greatly reduced.
Wounds under dressings heal in artificial conditions. This is an important factor, when drawing conclusions about the effect of a dressing on healing. Studies of wound healing have raised substantial doubt regarding the biological desirability of the widespread practice of merely cleansing a small wound and exposing it to drying air without some type of cover. Present roll-on bandages, of the type that may be wrapped around a body part, may be divided into:
(a) Bandages made of various knitted fabrics such as cotton or synthetic materials. These bandages have minimal stretch. They are typically fixed with an adherent tape or safety pin or a supplied fixation device. An example is Kling marketed by Johnson & Johnson.
These bandages easily loosen with movement and often have to be reapplied. Multi-overlapping of even these porous bandages will greatly reduce, if not completely abolish, their porosity.
Many woven bandages can be stretched along their length but do not stretch sideways. These products are most commonly used to retain dressings in position or in the treatment of sprains to restrict movement, to limit oedema in dependent parts and to hold large dressings in position. They are commonly known as supporting bandages.
(b) Bandages made of various knitted fabrics which include an elastic component which allow the bandage to be applied with some compression or tightness, to conform and maintain pressure on the area, e.g. a limb. An example is Elastocrepe marketed by Smith & Nephew. They have the same disadvantages as for (a) .
(c) Elasticised knitted fabric bandages with an adhesive on one side. The adhesive material fixes to the skin and between layers. An example is Elastoplast marketed by Smith & Nephew.
Again, their overlapping will greatly reduce, if not completely abolish, their porosity. Their unwinding is frequently difficult. Also, removal of the layer of bandage adherent to the skin is painful. The adhesive tends to perish with time, with a consequent loss of its adhesive properties. Some patients react to certain dressing adhesives, particularly when they are applied to regions of the body other than the hand.
Because of movement of the tissues, or when plasters or strapping are used to apply stresses to the body, for example orthopaedic strapping, the use of adhesive may cause considerable stresses and strains to develop at the adhesive/epidermal interface within the epidermis and at the epidermal/dermal junction, which may result in disruption of the tissues. Sweat glands and hair follicles may become occluded by the adhesive, and the evaporation of water vapour may be prevented.
Sometimes, in order to obtain adequate wound healing, the dressing must be changed often. Thus the repeated use of adhesive tape over the area of skin becomes a major factor in dressing changes. These tapes by nature are occlusive; that is they allow moisture to build up under them during wearing. This moisture over-hydrates and softens the outer layers of skin so that, when the tape is removed, these outer layers of skin are easily disrupted.
(d) Self-adherent wrap type bandages made of a crimped synthetic elastic material with a "bubbly" surface. When applied, they stretch. The nature of the surface of the bandage allows it to adhere together. An example is Coban marketed by 3M. When multi-layered, the porosity is abolished.
(e) Microporous tape made from a non-woven fibre with ' acrylic adhesives. Acrylic adhesive can be used repeatedly without causing trauma to the outer skin layers. There is permeability to liquid or water vapour only if applied as a single layer. However with overlapping, these advantages are lost. An example is Micropore tape marketed by 3M.
This type of tape does not stretch and cannot be used for compression.
Accordingly, the overlapping of porous dressings, bandages, strapping and plasters, adversely affects their porosity. This is a considerable disadvantage, with marked pathological effects on the skin and on wound healing. Suπvmarv of the Invention
According to this invention, a bandage is made of an elastomeric net-like sheet material which by virtue of an increased friction coefficient does not slip when overlapped, with multi-layering. It may have means whereby it can interlock with itself, as it is overlapped on itself when wound around a part. This is achieved by increasing the thickness and altering the shape at the cross-over points. When layered on itself, the cross-over points will lock into the pores of the net/mesh.
Because of the elastic nature of a net mesh, it will stretch and will conform with the area bandaged and thus maintain the original bandaged position. Movement or sliding of the layered material over itself can be avoided. The non-slippage is increased by the interlocking component in the design. The bandage is thus particularly suitable for maintaining pressure, where desired. No adhesive is required. It is thus particularly suitable for medical use, although it may be used to wrap any object. Description of the Invention
The self-locking bandage is of a different design to (d) . The novel bandage is an integral elastopolymer mesh/net and, where the filaments intersect with each other (the junctures) , the intersections are thickened in various shapes by increasing the volume of the polymer, preferably but not necessarily at each junction or intersection in three dimensions, so that there is a marked nubbing of the intersections as a "knob" or "blob" or "hook" . When the elasticised bandage of the invention is stretched and applied (e.g. to a limb) , in multilayering or overlapping on itself the projections at the junctions of any one layer
of the bandage interlock with both the adjacent inner and outer layers. The interlocking action combined with the high co-efficient of friction of the elastic polymer net material prevents the bandage from slipping and it thus maintains its conformity and pressure as required. The juncture points or "high spots" may be 5-10 times the thickness of the filaments and may be round, elliptical or squarish or any shape according to its method of manufacture, whether extrusion or moulding. The pores of the netting may be square, rectangular, round or any shape depending on the technique of manufacture. The elastomer net may stretch in any direction with stretching ratios of from 3/1 to 10/1.
As the bandage is tensed during its application this stretching increase the size of the pores. Despite multi-layering and overlapping, the holes in the net are of such a size that the skin is never completely occluded. Because it is a net-like material with large holes it allows perspiration and with cooling of the skin prevents overheating at the surface.
In material of the present invention, the mesh dimension is substantially larger than the filaments, so that the fabric has a high open area. For example, the mesh size may be 0.5 to 10, e.g. 1.5 to 5, mm, while the filament size may be 0.1 to 2.5 mm, for example 0.2 to 1.5 mm. This high ratio, e.g. of 1:1 to 25:1, means that, when layers of a strip of material according to the invention are superimposed after the strip is wrapped around a body part, the body is not occluded. This may assist healing, and permits washing.
In material of the invention, and as indicated above, protuberances allow superimposed layers to interlock. The protuberances may be provided on one or both faces of the material. If provided on one face only, the other face will usually be the body-contacting face. The protuberances will most conveniently be provided at the intersections of the filaments of the material, as has
previously been proposed in order to provide increased strength at the intersections, although they may also be present elsewhere on the filaments. These protuberances do not need to be accurately proportioned to fit into the pores of the fabric.
The accompanying drawing shows a highly schematic partial plan view of material for use in the invention and also a schematic sectional view of the material when wrapped around on itself, e.g. over a wound (not shown) . This view may be considered as an expanded section, or in a state prior to tightening, when the layers are brought into closer contact. The protuberances are staggered in superimposed layers, so that they interlock with the open mesh in one or both adjacent layers. Another application of the elastomer netting as described comprises introducing a "filler" in the openings, e.g. an absorbent, air-permeable material. Such a material need not limit the elasticity or compromise the interlocking of the intersecting "knobs". For example, the openings of the net material may be filled with a cotton or synthetic wool type material, or paper material in a thin layer in such a way as to allow the expansile or stretching nature of the intersecting filaments. The elastic net bandage is able to incorporate a material for absorbency but remains compliant enough to allow the projecting junctions to enter the holes.
Claims
1. An elongate strip of an integral reticulated elastomeric polymer material, in which the mesh dimension thereof is substantially larger than the filaments, and which has surface protuberances, for therapeutic use as a bandage by wrapping it around a body part so that layers thereof are superimposed and interlock, without occlusion of the body.
2. A strip according to claim 1, in which the mesh size is 1.5 to 5 mm.
3. A strip according to claim 1 or claim 2, in which the filament thickness is 0.2 to 1.5 mm.
4. A strip according to any preceding claim, additionally comprising an air-permeable absorbent filler material.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9605863.1A GB9605863D0 (en) | 1996-03-20 | 1996-03-20 | Bandage |
GB9605863.1 | 1996-03-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1997034553A1 true WO1997034553A1 (en) | 1997-09-25 |
Family
ID=10790725
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB1997/000784 WO1997034553A1 (en) | 1996-03-20 | 1997-03-20 | Bandage |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB9605863D0 (en) |
WO (1) | WO1997034553A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005070361A1 (en) * | 2004-01-14 | 2005-08-04 | Apex Mills Corporation | Scab protecting bandage |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB794397A (en) * | 1956-07-11 | 1958-04-30 | Kimberly Clark Co | Improvements in and relating to absorbent dressings |
US4235237A (en) * | 1978-05-08 | 1980-11-25 | Johnson & Johnson | Absorbent open network structure |
US4921704A (en) * | 1986-03-10 | 1990-05-01 | Molnlycke Ab | Wound dressing |
WO1995012373A1 (en) * | 1993-11-03 | 1995-05-11 | Smith & Nephew Plc | Padding |
-
1996
- 1996-03-20 GB GBGB9605863.1A patent/GB9605863D0/en active Pending
-
1997
- 1997-03-20 WO PCT/GB1997/000784 patent/WO1997034553A1/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB794397A (en) * | 1956-07-11 | 1958-04-30 | Kimberly Clark Co | Improvements in and relating to absorbent dressings |
US4235237A (en) * | 1978-05-08 | 1980-11-25 | Johnson & Johnson | Absorbent open network structure |
US4921704A (en) * | 1986-03-10 | 1990-05-01 | Molnlycke Ab | Wound dressing |
WO1995012373A1 (en) * | 1993-11-03 | 1995-05-11 | Smith & Nephew Plc | Padding |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005070361A1 (en) * | 2004-01-14 | 2005-08-04 | Apex Mills Corporation | Scab protecting bandage |
US7176343B2 (en) | 2004-01-14 | 2007-02-13 | Ed Schlussel | Scab protecting bandage |
Also Published As
Publication number | Publication date |
---|---|
GB9605863D0 (en) | 1996-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7951124B2 (en) | Growth stimulating wound dressing with improved contact surfaces | |
AU2007269627B2 (en) | Growth stimulating wound dressing with improved contact surfaces | |
AU2005235134B2 (en) | Wound contact device | |
AU2011270739B2 (en) | Secondary wound dressings for securing primary dressings and managing fluid from wounds, and methods of using same | |
US8586818B2 (en) | Wound shield | |
US10517767B2 (en) | Application of kinesiology tape bandage | |
US5499966A (en) | Tubular bandages | |
CA2296077A1 (en) | Medical protective wrap | |
US20220087869A1 (en) | Method of manufacturing a component for a wound dressing | |
US7838719B2 (en) | Bandage for covering a wound with no adhesive-to-skin contact | |
US7745683B2 (en) | Deformable and conformable wound protecting apparatus and its method of application | |
EP1154747A1 (en) | Compression sponge for wound care | |
WO1997034553A1 (en) | Bandage | |
WO2002102425A2 (en) | Compound hydrogel wound dressing | |
GB2302669A (en) | Non-woven textile material for dressings and articles of hygiene | |
WO2009004282A2 (en) | Medical dressing | |
CN220360497U (en) | Band-aid with local anesthesia pain relieving function | |
KR100415259B1 (en) | The bandage for burns | |
JPH077940Y2 (en) | Medical patch | |
JPH04282152A (en) | Hydrophobic wound coating material | |
Byrne | Wound Management and Bandaging | |
Pudner | Which Dressing?: Part Two | |
Navarrete Jr et al. | A Student-Friendly Guide for the Selection of Wound Care Dressings for the Foot and Ankle |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): JP US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: CA |
|
NENP | Non-entry into the national phase |
Ref country code: JP Ref document number: 97533271 Format of ref document f/p: F |
|
122 | Ep: pct application non-entry in european phase |